Personalized medicine represents a paradigm shift in cancer treatment, moving away from the one-size-fits-all approach to therapies tailored to individual patients' genetic profiles. By understanding the unique genetic and molecular landscape of a patient's tumor, clinicians can select treatments that are more likely to be effective. This approach not only improves outcomes but also minimizes adverse effects, ultimately enhancing the quality of life for patients.
